Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

SL Thrower, L James, W. Hall, KM Green, S Arif, JS Allen, C Van-Krinks, B Lozanoska-Ochser, LG Marquesini, S Brown, FS Wong, CM Dayan, M Peakman

Research output: Contribution to journalArticle (Academic Journal)peer-review

104 Citations (Scopus)
Translated title of the contributionProinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
Original languageEnglish
Pages (from-to)156 - 165
Number of pages10
JournalClinical and Experimental Immunology
Volume155
Publication statusPublished - Feb 2009

Cite this